Pharmaceuticals Singapore

Singapore Precision Oncology Market Analysis, 2024–2034

Singapore Precision Oncology Market Industry Trends and Forecast to 2034: Segmented by (Product, Cancer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $126.4 Mn Estimated value
Estimate 2025 $139.6 Mn 0.1% of the global market
Projected 2034 $340.0 Mn 143.6% Adds $200.4 Mn over 9 forecast years
CAGR 2025–2034 10.4% Faster than 61% of 180 Pharmaceuticals markets here
Key players 5
  • Singapore is 0.12% of the global market.
  • In APAC, the largest is China at $10.57 Bn.
  • Fastest growing: India at 12.8% a year.
  • Singapore ranks 9th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$200.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Precision Oncology Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $126.4 Mn — —
2025 (base) $139.6 Mn +$13.1 Mn —
2026 (forecast) $154.1 Mn +$14.5 Mn +10.4%
2027 (forecast) $170.1 Mn +$16.0 Mn +21.9%
2028 (forecast) $187.8 Mn +$17.7 Mn +34.6%
2029 (forecast) $207.3 Mn +$19.5 Mn +48.6%
2030 (forecast) $228.9 Mn +$21.6 Mn +64%
2031 (forecast) $252.7 Mn +$23.8 Mn +81.1%
2032 (forecast) $279.0 Mn +$26.3 Mn +99.9%
2033 (forecast) $308.0 Mn +$29.0 Mn +120.7%
2034 (forecast) $340.0 Mn +$32.0 Mn +143.6%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $114.95 Bn
  2. North America $59.45 Bn
  3. US $46.76 Bn
  4. Europe $22.70 Bn
  5. APAC $22.50 Bn
  6. Canada $10.53 Bn
  7. China $10.57 Bn
  8. Japan $8.11 Bn
  9. Latin America $6.03 Bn
  10. Middle East $5.12 Bn
  11. Germany $4.66 Bn
  12. Italy $3.08 Bn
  13. Brazil $3.15 Bn
  14. UK $2.98 Bn
  15. France $2.72 Bn
  16. India $2.49 Bn
  17. Spain $2.31 Bn
  18. Ecuador $2.31 Bn
  19. Saudi Arabia $1.97 Bn
  20. Africa $1.93 Bn
  21. Mexico $1.67 Bn
  22. New Zealand $1.28 Bn
  23. Australia $1.28 Bn
  24. Russia $1.10 Bn
  25. South Africa $676.5 Mn
  26. UAE $548.9 Mn
  27. Egypt $377.9 Mn
  28. Philippines $254.8 Mn
  29. Malaysia $181.0 Mn
  30. Hong Kong $169.5 Mn
  31. Singapore (this report) $139.6 Mn
  32. Thailand $123.8 Mn
  33. Kenya $90.3 Mn

The Singapore Precision Oncology Market Analysis Executive Summary

Precision oncology matches cancer treatment to the genetic changes in a patient's tumour, using tests and targeted drugs.

Key segments of the precision Oncology market include product (Genomic Tests, Targeted Therapies and Informatics Platforms) and cancer (Lung, Breast and Colorectal).

Singapore Precision Oncology Market Dynamics

Market Growth Drivers

Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the precision Oncology market. Faster approvals and new combinations are improving survival.

Opportunity

Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the precision Oncology market.

Market Restraints

High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the precision Oncology market, especially in low- and middle-income countries.

Competitive Landscape for Precision Oncology Market in Singapore

The precision Oncology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Precision Oncology Market in Singapore

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for precision Oncology. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Precision Oncology right now, from free public sources.

Clinical trials

5 active trials in Singapore

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Tempus 5 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Orca Biosystems, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 7,542 papers since 2021 (worldwide)

  1. Interpreting and Validating a Deep Learning Model Predictive of Spatial Morphologic-Molecular Patterns in Lung Adenocarcinoma, Using Ground Truth Immunohistochemistry Images. The American journal of pathology, 2026
  2. B3GNT3 in cancer: catalysis-dependent and catalysis-independent mechanisms, biomarker readiness and therapeutic targeting. Critical reviews in oncology/hematology, 2026
  3. Lynch syndrome. Lancet (London, England), 2026
  4. Polydopamine-modified BODIPY-encoded polystyrene microspheres for highly sensitive multiplexed miRNA detection. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2026
  5. APOBEC3-mediated therapy resistance and immunogenicity in solid tumors: from genomic scars to therapeutic vulnerabilities. ESMO open, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Precision Oncology in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How many clinical trials on Precision Oncology are running in Singapore?
5 studies are recruiting, active or about to start in Singapore.[4]
How much research is published on Precision Oncology?
PubMed lists 7,542 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Singapore. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Precision Oncology in Singapore? Our analysts can size it for your plan. Talk to us See the public data Early deaths from long-term diseases (WHO) for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Bioinformatics: Making Sense of Health DataSequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Singapore

See all
Same topic, other categories

Related on oncology and genomics

See the topic